INVESTMENTS THAT MATTER
Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.
Across all stages of development, we align ourselves with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients’ lives.
OUR PROVEN STRATEGY
At Agent Capital, we proactively guide biotech companies to milestones and exits.
With a balanced investment approach and a deep understanding of biopharma’s pipeline pressures, we are committed to making investments that move healthcare forward – no matter the stage or investment type.
TYPICALLY, OUR KEY INVESTMENT AREAS OF FOCUS INCLUDE:
Rare Diseases
Oncology
Neurology
Immunology
Featured Portfolio Company
Dice Therapeutics
Entrada Therapeutics
Zenas Biopharma
Star Therapeutics
Pyxis Oncology
Precision Biosciences
Orchard Therapeutics
Palvella Therapeutics
Carisma Therapeutics
Interius BioTherapeutics
Pliant Therapeutics
Skyhawk Therapeutics
Verge Genomics
ImCheck Therapeutics
Freenome
Dragonfly Therapeutics
Affini-T